|
Sinovac Biotech Ltd
Ticker Symbol: SVA CUSIP: P8696W104 Previous CUSIP: Exchange: NGS
Company's Online Profile
BUSINESS: Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including hepatitis A and B, seasonal influenza, H5N1 pandemic influenza (avian flu), H1N1 influenza (swine flu), and mumps, as well as animal rabies vaccine for canines. Sinovac was the first company worldwide to receive approval for their H1N1 influenza vaccine, Panflu.1, and has manufactured it for the Chinese Central Government, pursuant to the government-stockpiling program. The company is also the only supplier of the H5N1 pandemic influenza vaccine to the government-stockpiling program. Sinovac is developing a number of new pipeline vaccines including vaccines for enterovirus 71 (against hand, foot, and mouth disease), of which the EV71 vaccine is currently in Phase III clinical trials, pneumococcal conjugate, pneumococcal polysaccharides, and rubella. Sinovac sells their vaccines mainly in China and exports selected vaccines to Mongolia, Nepal, and the Philippines.
|
Changed: 1/01/00
Changed: 1/01/00
Mid Cap Stock -
Market Value $ Million
Click for current SVA price quote from the NASDAQ
Yahoo News Summary for SVA
YAHOO! Profile for SVA
Yahoo Detailed Quote
MarketWatch Quote
MSN Company Report for SVA
|
Company's Online Information Links
|
| Company's Online SEC EDGAR Filings |
| Company's Email Address Links |
| Foreign Address and Phone Numbers |
| Address: No. 15 Zhi Tong Road, Zhongguancun Science & Technology Park, Changping Dist, Beijing 102200, PRC |
| Main Phone Number |
+86-10-8279 9720 |
| Fax Number |
+86-10-6296-6910 |
Find a problem? Please use our Feedback Page or Email us.
Have you filled out our Guestbook? If not, please do.
|
|
